Results 91 to 100 of about 6,121 (198)

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation

open access: yesКардиоваскулярная терапия и профилактика, 2006
Aim. To study the effects of three-month propafenone antiarrhythmic therapy (daily dose 450 mg) on inotropic myocardial function in patients with recurrent atrial fibrillation (AF). Material and methods.
I. G. Fomina   +2 more
doaj  

Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.

open access: yes, 1988
Twenty-four patients aged 10.1 +/- 4.5 (mean +/- SD) years with recurrent paroxysmal supraventricular tachycardia underwent an electrophysiological study.
B Musto   +3 more
core   +1 more source

Atrial fibrillation and the pharmacological treatment: the role of propafenone

open access: yes, 2012
Atrial fibrillation is the most frequent cardiac rhythm disturbance, with prevalence increasing with age. This disease is a major risk factor for ischaemic stroke. The costs resulting from atrial fibrillation are really impressive. Pharmacological agents
Sestito, Alfonso
core  

Ensanchamiento del complejo QRS: ¿hiperkalemia? ¿propafenona?

open access: yesRevista Cubana de Cardiología y Cirugía Cardiovascular, 2012
RESUMEN La hiperkalemia y la propafenona  son condiciones que enlentecen la velocidad de conducción intracardiaca. Se presenta  una paciente que en el curso de una hiperkalemia moderada y con dosis bajas de propafenona mostró una taquicardia sinusal con
Marleny Cruz Cardentey   +2 more
doaj  

Choosing a class IC antiarrhythmic drug for the treatment of patients without structural heart disease: clinical advantages of the most common agents (literature review)

open access: yesСучасні медичні технології
Aim: to analyze the pharmacological features and updated evidence-based medicine data of Class IC antiarrhythmic drug (AAD) ethacizine compared to propafenone to optimize the choice of treatment for cardiac arrhythmias in patients without structural ...
N. M. Sydorova, M. Yu. Kolesnyk
doaj   +1 more source

Reduced progression of atrial fibrillation in hypertensive patients with long-term treatment of propafenone

open access: yesКардиоСоматика, 2016
In recent years, progress has been made in the study of the natural history of atrial fibrillation (AF) - that, from the stage of having no clinical manifestations, to the final stage, which is an irreversible arrhythmia, is associated with the ...
A. I Tarzimanova, V. I Podzolkov
doaj  

A Case of Propafenone Toxicity in the Setting of Dehydration and Acute Kidney Injury [PDF]

open access: yes
Propafenone is a class 1C antiarrhythmic and is one of the first-line drugs used in the management of atrial fibrillation. Its toxicity is rare, yet potentially life-threatening.
Haddad, Enad, Collins, Matthew
core  

SIMULTANEOUS ESTIMATION OF PROPAFENONE AND ITS TWO METABOLITES IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY LC-MS/MS [PDF]

open access: yes, 2017
Objective: A simple, sensitive and rapid performance liquid chromatography/positive ion electrospray tandem mass spectrometry method was to be developed and validated for quantification of propafenone (PPF) and its two major metabolite 5-hydroxy ...
Mishra, Brijeshkunvar   +2 more
core  

Results of propafenone use in early postoperative period after pulmonary veins catheter radiofrequency isolation for prevention of early atrial tachyarrhythmias

open access: yesКардиоСоматика, 2015
Currently pulmonary veins isolation becomes one of the approaches for invasive treatment of paroxysmal atrial fibrillation (AF). One of difficult and unexplored problems associated with this procedure is management of patients in postoperative period ...
A. V Tarasov   +2 more
doaj  

Lethal toxicity of propafenone in a case of suicidal attempt

open access: yes, 2007
Propafenone is a well-established IC class antiarrhythmic drug widely used in the treatment of a variety of supraventricular and ventricular tachyarrhythmias. Propafenone has been widely used in clinical practice in recent years.
Ustundag, Mehmet   +4 more
core  

Home - About - Disclaimer - Privacy